The Virtual Tumor Board Management of Metastatic, PDL1 Negative NSCLC
Aug 13, 2022
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the management of metastatic, PDL1 negative NSCLC. He is joined by Dr. Hossein Borghaei and Dr. Reyes Bernabe Caro.
Dr. Borghaei is a professor and Chief of Thoracic Oncology at Fox Chase Cancer Center in Philadelphia. He was the lead author for CheckMate 057, was involved in many of the landmark immunotherapy trials, and is the national PI for the ongoing INSIGNA trial. Dr. Reyes Bernabe Caro is the Section Chief of Medical Oncology and Head of the Thoracic Tumor Unite at the Hospital Universitario Virgen Rocio in Seville, Spain. She also has extensive experience in immunotherapy combinations and is an author on the NADIM and CheckMate 227 studies.
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Chief of the Division of Thoracic Medical Oncology, Department of Hematology/Oncology
Fox Chase Cancer Center, Temple University Hospital